Targeted Therapy on the Screen: Do We Hit the Target?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36240006.
- Also identified by DOI 10.1158/1078-0432.CCR-22-2707.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A phase II trial, investigating whether the antidiabetic drug metformin could reduce hypoxia in cervical cancer, used imaging to preselect patients and test the biological hypothesis behind the drug effect. This trial design would be of importance for the implementation of targeted treatment in the clinic. See related article by Han et al., p. 5263.
Medical subject headings
- Metformin
- Uterine Cervical Neoplasms